How inflammation changes bone-building cells and bone repair
Official title: Mechanisms of inflammatory osteoblastogenesis and bone formation
Funded at Hospital for Special Surgery · NIH-11237128 · Data updated 2026-11-12
This work looks at whether turning down an overactive interferon-related signal in bone-forming cells can help people with inflammatory bone loss, such as rheumatoid arthritis, rebuild bone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Hospital for Special Surgery NIH-funded |
| Lab location | 1 site (New York, UNITED STATES) |
| Project start | December 1, 2024 |
| Project end | November 30, 2029 |
| Funding year | 2026 |
| Award (this year) | $688,634 |
| NIH project number | 5R01AG092357-02 |
| Project ID | NIH-11237128 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with inflammatory bone-loss conditions (for example rheumatoid arthritis or severe periodontitis) would be the most relevant group for future clinical work stemming from this research.
✕Less likely to help
People whose bone loss is primarily non-inflammatory (for example age-related osteoporosis without inflammatory disease) or children under 21 are less likely to benefit from these findings.
What this research studies
You should know that inflammation can cause too much bone breakdown while blocking the cells that normally make new bone. The researchers discovered that bone-forming cells carry a constant type I interferon signal and that a gene called Eif2ak2 appears to limit bone formation. In the lab they will use cultured bone cells and animal models to see how this interferon response and Eif2ak2 control osteoblast development and bone repair. The goal is to find molecular targets that could be used later to help restore bone formation in inflammatory conditions.
Why it matters
Potential benefit: If successful, this work could point to new ways to restore bone formation for people with inflammatory bone loss like rheumatoid arthritis or severe periodontitis.
How similar studies have gone: Early laboratory data identified an interferon signature in osteoblasts and flagged Eif2ak2 as an inhibitor, but applying this approach to boost bone formation in patients is largely new and untested clinically.
Where this research is happening
-
Hospital for Special Surgery
New York, United States Active
Researchers
- Principal investigator: Zhao, Baohong — Hospital for Special Surgery
- Study coordinator: Zhao, Baohong
Related research
Other NIH-funded projects on the same topics.
-
Subjective thinking challenges in adults with lupus as they age
This grant aims to understand how lupus-related cognitive problems affect adults, especially older adults, and tests a real-time method to track daily fluctuations in those symptoms.
-
How bone density and joint loads affect implant migration after knee replacement
A knee replacement project explores how bone density and how the knee is loaded relate to early implant movement that could lead to loosening.
-
ctDNA biomarker to guide safety of cancer immunotherapy in inflammatory arthritis
A patient-facing biomarker study using a blood test to detect tumor DNA in people with cancer who develop inflammatory arthritis from immunotherapy, to help doctors pick safer treatment choices.
-
Glucocorticoid-regulated transcription networks in macrophage biology
A scientist-led project will study how stress-related hormones and immune signals control macrophages, which are key players in inflammation and tissue repair.
-
Targeting bone-resorbing osteoclasts with cell-specific therapies
A doctor-research team is exploring a new way to treat bone diseases by targeting the blood-forming cells that become osteoclasts, aiming to reduce bone loss and side effects for patients.
-
Osteoclast programming and reprogramming during bone formation and disease
A research project explores how bone-resorbing cells called osteoclasts are controlled at the genetic level to find ways to prevent or slow bone loss in conditions like osteoporosis and rheumatoid arthritis.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.